Resumo

RONDAN, Paola L et al. High frequency of dyslipidemia in HIV-infected patients in a peruvian public hospital. Rev. perú. med. exp. salud publica [online]. 2017, vol.34, n.2, pp.239-244. ISSN 1726-4634.  http://dx.doi.org/10.17843/rpmesp.2017.342.2587.

The objective of the study was to determine the frequency and characteristics of dyslipidemia in patients with HIV in highly active antiretroviral therapy (HAART) in a Peruvian public hospital. A cross-sectional study was carried out in patients with complete lipid profile after receiving at least six months of HAART. Dyslipidemia was defined according to the criteria of the NCEP-ATP III. We reviewed 2 975 clinical histories, and included 538 (18.1%) in the analysis. The frequency of dyslipidemia was 74.7%. HAART regimens which include protease inhibitors (PI) (odds ratio [OR]: 1.22; confidence interval at 95% [CI 95%]: 1.11-1.33) and to be older than 40 years (OR: 1.17; CI 95%: 1.05-1.28) were associated with dyslipidemia, adjusted by viral load, CD4 lymphocyte level and gender. In conclusion, dyslipidemia was very common in our sample and was mainly associated with the use of PI. It is necessary to promote the dyslipidemia control as part of the comprehensive care of the patient with HIV.

Palavras-chave : Dyslipidemias; HIV; Antiretroviral therapy; highly active.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )